logo

Icon Plc (ICLR)



Trade ICLR now with
  Date
  Headline
10/25/2022 10:54:58 AM ICON Stock Gains 8%
10/6/2022 8:12:12 AM ICON Selected By BARDA To Conduct Anthrax Vaccine Clinical Trial
2/22/2022 6:19:34 AM ICON Plc Q4 EPS $0.92 Vs $1.90 Last Year
1/12/2022 7:07:51 AM ICON Reaffirms 2021 Adj. EPS In Range Of $9.55 - $9.75; Revenue Of $5.43 Bln - $5.53 Bln
7/21/2021 6:09:04 AM ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting
7/1/2021 8:51:55 AM ICON Completes Acquisition Of PRA Health Sciences
6/14/2021 8:05:03 AM ICON Plans Private Offering Of Senior Secured Notes
2/24/2021 6:25:19 AM ICONplc Q4 EPS Increases By 4% To $1.90; Adj. EPS $1.90 Increase Of 4.0%
2/24/2021 6:08:57 AM ICON To Acquire PRA Health Sciences In Cash And Stock Transaction Valued At About $12 Bln
2/16/2021 7:43:47 AM Cytocom Provides Update Regarding Its CYTO-200 Portfolio Of Clinical Programs
9/11/2018 7:06:05 AM William Blair Is Increasing ICON Plc (ICLR) FY20 Estimate To 7.69 From 7.67
1/10/2017 7:56:37 AM William Blair Is Lowering ICON Plc (ICLR) 2017 Rev. Estimate To 1.73 Billion From 1.75 Billion
1/10/2017 7:55:52 AM William Blair Is Lowering ICON Plc (ICLR) 2017 Estimate To 5.12 From 5.19
10/22/2014 7:49:10 AM ICON Plc (ICLR) Has Lowered Its 2014 Revenue Estimate To $1495 Mln - $1515 Mln From $1490 Mln - $1530 Mln
10/22/2014 6:11:21 AM ICON Plc (ICLR) Has Raised Its 2014 EPS Estimate To 2.74 - 2.79 From 2.62 - 2.68
7/30/2014 7:03:19 AM ICON Plc (ICLR) Has Raised Its 2Q14 EPS Estimate To 2.62 - 2.68 From 2.30 - 2.40
10/24/2013 9:25:19 AM ICON Plc (ICLR) Has Raised Its 2013 EPS Estimate To 1.67 - 1.70 From 1.54 - 1.64